Literature DB >> 7507231

Scanning the structure and antigenicity of HPV-16 E6 and E7 oncoproteins using antipeptide antibodies.

S N Stacey1, C Eklund, D Jordan, N K Smith, P L Stern, J Dillner, J R Arrand.   

Abstract

The structure and antigenicity of the HPV-16 E6 and E7 oncoproteins was studied using a set of antisera against overlapping synthetic peptides. We report that antigenic, mobile regions of the native proteins, as defined by reactivity with antipeptide antisera, occur at the N-termini of both E6 and E7 proteins, corresponding to regions of known or suspected protein-protein interactions. The putative zinc finger domains were consistently non-reactive, despite computer predictions of relatively high antigenicity, suggesting that the proposed zinc finger regions are held in stable secondary structures that the peptides were not able to mimic. In E6, the linker region between the two zinc fingers was antigenic, indicating that the two zinc finger structures might be able to articulate relative to one another by a flexible linker region. The highly antigenic N-terminal region of HPV-16 E7 was also found to be antigenic in E7 of both HPV-11 and HPV-18, indicating that the E7 proteins of different HPV types have similar antigenic structures. The identification of antigenic regions of the E6 and E7 proteins should be therefore be useful in the design of site-directed antibodies against E6 and E7 for numerous HPV types.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507231

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Leaky scanning is the predominant mechanism for translation of human papillomavirus type 16 E7 oncoprotein from E6/E7 bicistronic mRNA.

Authors:  S N Stacey; D Jordan; A J Williamson; M Brown; J H Coote; J R Arrand
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.

Authors:  Qinglong Shang; Yan Wang; Yong Fang; Lanlan Wei; Sijia Chen; Yuhui Sun; Baoxin Li; Fengmin Zhang; Hongxi Gu
Journal:  J Clin Microbiol       Date:  2011-05-18       Impact factor: 5.948

3.  Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame.

Authors:  S N Stacey; D Jordan; P J Snijders; M Mackett; J M Walboomers; J R Arrand
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.

Authors:  T Yamada; C M Wheeler; A L Halpern; A C Stewart; A Hildesheim; S A Jenison
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

5.  Differences in serological IgA responses to recombinant baculovirus-derived human papillomavirus E2 protein in the natural history of cervical neoplasia.

Authors:  L Rocha-Zavaleta; D Jordan; S Pepper; G Corbitt; F Clarke; N J Maitland; C M Sanders; J R Arrand; P L Stern; S N Stacey
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

Authors:  M E Boursnell; E Rutherford; J K Hickling; E A Rollinson; A J Munro; N Rolley; C S McLean; L K Borysiewicz; K Vousden; S C Inglis
Journal:  Vaccine       Date:  1996-11       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.